Pharmacotherapy. 2002 Jul;22(7):930-3.

Central nervous system adverse effects with efavirenz: case report and review.

Source

Department of Psychiatry, San Francisco General Hospital, California 94110, USA.

Abstract

Efavirenz is a nonnucleoside reverse transcriptase inhibitor that can be given with other antiretroviral agents for the treatment of human immunodeficiency virus infection. A 47-year-old man with acquired immunodeficiency syndrome developed severe depression and suicidal ideation necessitating psychiatric hospitalization and antidepressant therapy. The symptoms occurred in temporal relation to the introduction of efavirenz into his highly active antiretroviral therapy regimen. Similar serious psychiatric adverse effects have been associated with this agent. Clinicians should monitor for central nervous system adverse effects in all patients taking efavirenz.

PMID:: 12126226; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. [Pediatrics. 2003]
Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A, First Pediatric Switch Study. Pediatrics. 2003 Mar; 111(3):e275-81.
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring. [Clin Infect Dis. 2005]
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.
Gutiérrez F, Navarro A, Padilla S, Antón R, Masiá M, Borrás J, Martín-Hidalgo A. Clin Infect Dis. 2005 Dec 1; 41(11):1648-53. Epub 2005 Oct 19.
[Apropos of atypical melancholia with Sustiva (efavirenz)]. [Encephale. 2001]
[Apropos of atypical melancholia with Sustiva (efavirenz)].
Lang JP, Halleguen O, Picard A, Lang JM, Danion JM. Encephale. 2001 May-Jun; 27(3):290-3.
Review Neuropsychiatric side effects of efavirenz therapy. [Expert Opin Drug Saf. 2007]
Review Neuropsychiatric side effects of efavirenz therapy.
Arendt G, de Nocker D, von Giesen HJ, Nolting T. Expert Opin Drug Saf. 2007 Mar; 6(2):147-54.
Review Efavirenz-associated gynecomastia: report of five cases and review of the literature. [Breast J. 2004]
Review Efavirenz-associated gynecomastia: report of five cases and review of the literature.
Jover F, Cuadrado JM, Roig P, Rodríguez M, Andreu L, Merino J. Breast J. 2004 May-Jun; 10(3):244-6.

See reviews... See all...

Cited by 3 PubMed Central articles

Neuropsychiatric sequelae in an efavirenz treated patient with hepatitis B. [BMJ Case Rep. 2009]
Neuropsychiatric sequelae in an efavirenz treated patient with hepatitis B.
Salter E, Patel AS. BMJ Case Rep. 2009; 2009. Epub 2009 Nov 26.
Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients. [Antimicrob Agents Chemother. 2...]
Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.
Sánchez A, Cabrera S, Santos D, Valverde MP, Fuertes A, Domínguez-Gil A, García MJ, Tormes Group. Antimicrob Agents Chemother. 2011 Nov; 55(11):5314-24. Epub 2011 Sep 6.
Review Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. [Subst Abus. 2008]
Review Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.
Khalsa JH, Treisman G, McCance-Katz E, Tedaldi E. Subst Abus. 2008; 29(3):5-16.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Central nervous system adverse effects with efavirenz: case report and review.
Central nervous system adverse effects with efavirenz: case report and review.
Pharmacotherapy. 2002 Jul ;22(7):930-3.

PubMed
Transimmunization, a novel approach for tumor immunotherapy.
Transimmunization, a novel approach for tumor immunotherapy.
Transfus Apher Sci. 2002 Jun ;26(3):205-16.

PubMed
Onion juice (Allium cepa L.), a new topical treatment for alopecia areata.
Onion juice (Allium cepa L.), a new topical treatment for alopecia areata.
J Dermatol. 2002 Jun ;29(6):343-6.

PubMed
A new calcipotriol/betamethasone formulation with rapid onset of action was supe...
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Acta Derm Venereol. 2002 ;82(2):131-5.

PubMed
The Niemann-Pick C proteins and trafficking of cholesterol through the late endo...
The Niemann-Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system.
Curr Mol Med. 2002 Aug ;2(5):485-505.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: